Evidence map›Paper›PMID 25120702›Full record

ArticleOncology letters2014

Isolated duodenal myeloid sarcoma associated with the

Bo Huang, Peng You, Ping Zhu, Zunguo DU, Beiqian Wu, Xiaoping Xu, Zi Chen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature.Mediterranean journal of hematology and infectious diseases · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bo HuangDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Peng YouDepartment of Gastroenterology, People's Hospital, Peking University, Beijing 100044, P.R. China.
Ping ZhuDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Zunguo DUDepartment of Pathology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Beiqian WuDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Xiaoping XuDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Zi ChenDepartment of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Fudan University · CNHuashan Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcoma (MS) is a rare disease that presents as an extramedullary tumorous mass of immature myeloid precursors. The majority of MS are identified in acute myeloid leukemia (AML) patients and rarely present as a primary isolated MS without AML. In addition, inversion of chromosome 16 [inv(16)] and the

Indexed as

acute myeloid leukemiaCBFβ/MYH11 fusion genemyeloid sarcoma

Identifiers

PMID25120702
PMCPMC4114609
OpenAlexW2054165333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.